Advertisement
Screener

ULTRAGENYX PHARMACEUTICAL INC. (RARE) Lessee, Operating Lease, Liability, to be Paid, Year Four

2.3 / 5 stars · 39/83 Roast Me

ULTRAGENYX PHARMACEUTICAL INC. Lessee, Operating Lease, Liability, to be Paid, Year Four

ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Lessee, Operating Lease, Liability, to be Paid, Year Four of $7.00 million as of 2025-12-31, per its 10-K filed 2026-02-18.

Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2026-02-18

  • 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $7.00M.
  • 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $6.71M.
  • 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $5.87M.
  • 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $2.96M.
Period endLessee, Operating Lease, Liability, to be Paid, Year Four
2025-12-31$7.00M
10-K · filed 2026-02-18
2024-12-31$6.71M
10-K · filed 2025-02-19
2023-12-31$5.87M
10-K · filed 2024-02-21
2022-12-31$2.96M
10-K · filed 2023-02-17
2021-12-31$6.25M
10-K · filed 2022-02-15
2020-12-31$10.32M
10-K · filed 2021-02-12
2019-12-31$7.54M
10-K · filed 2020-02-14
2019-09-30$7.43M
10-Q · filed 2019-11-06
2019-06-30$7.43M
10-Q · filed 2019-08-02
2019-03-31$4.95M
10-Q · filed 2019-05-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
OMEROS CORP (OMER)United States$1.456B5.50
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82